0001144204-16-112017.txt : 20160707 0001144204-16-112017.hdr.sgml : 20160707 20160707164422 ACCESSION NUMBER: 0001144204-16-112017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160706 FILED AS OF DATE: 20160707 DATE AS OF CHANGE: 20160707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG MICHAEL M CENTRAL INDEX KEY: 0000905011 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 161757000 MAIL ADDRESS: STREET 1: C/O MONTAUR CAPITAL PARTNERS STREET 2: 152 WEST 57TH STREET, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 v443798_4.xml OWNERSHIP DOCUMENT X0306 4 2016-07-06 0 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0000905011 GOLDBERG MICHAEL M 5600 BLAZER PARKWAY, SUITE 200 DUBLIN OH 43017 1 0 0 0 Common Stock 2016-07-06 4 A 0 43580 0.50 A 403152 D Acquired from Issuer in lieu of cash compensation for board services during the second quarter of 2016. /s/ Kevin W. Waite 2016-07-07